Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: A US-based study*

Author： Frei C. R.   Jaso T. C.   Mortensen E. M.   Restrepo M. I.   Raut M. K.   Oramasionwu C. U.   Ruiz A. D.   Makos B. R.   Ruiz J. L.   Attridge R. T.   Mody S. H.   Fisher A.   Schein J. R.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.25, Iss.4, 2009-04, pp. : 859-868

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis

By Klausner Howard A.   Brown Patricia   Peterson Janet   Kaul Simrati   Khashab Mohammed   Fisher Alan C.   Kahn James B.  

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2637-2645

Informa Healthcare

Access to resources Recommend Favorite

Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia

By File Thomas M.   Milkovich Gary   Tennenberg Alan M.   Xiang Jim X.   Khashab Mohammed M.   Zadeikis Neringa  

Current Medical Research and Opinion, Vol. 20, Iss. 9, 2004-09 ,pp. : 1473-1481

Informa Healthcare

Access to resources Recommend Favorite

A Prospective, Randomized, Multicenter Comparative Study of Clinafloxacin Versus a Ceftriaxone-based Regimen in the Treatment of Hospitalized Patients with Community-acquired Pneumonia

By Petermann W.   Alegre-Martin J.   Odenholt I.   Phillips M. J.   Willcox P. A.   Tack K.   Trostmann U.   Welling L.  

Scandinavian Journal of Infectious Diseases, Vol. 33, Iss. 11, 2001-11 ,pp. : 832-837

Informa Healthcare

Access to resources Recommend Favorite

Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with non-gonococcal urethritis

By Takahashi Satoshi   Ichihara Kohji   Hashimoto Jiro   Kurimura Yuichiro   Iwasawa Akihiko   Hayashi Kenji   Sunaoshi Kenichi   Takeda Koichi   Suzuki Nobukazu   Satoh Takashi   Tsukamoto Taiji  

Journal of Infection and Chemotherapy, Vol. 17, Iss. 3, 2011-06 ,pp. : 392-396

Springer Publishing Company

Access to resources Recommend Favorite

A cost-minimisation analysis comparing moxifloxacin with levofloxacin plus ceftriaxone for the treatment of patients with community-acquired pneumonia in Germany: results from the MOTIV trial

By Lloyd A.   Holman A.   Evers T.  

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1279-1284

Informa Healthcare

Access to resources Recommend Favorite